[{"AccountsPayableCurrent_0_Q2_USD":1847000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5486000.0,"OtherAssetsNoncurrent_0_Q2_USD":11558000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-114000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":404000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-738000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-624000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-1024000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":6957000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-373000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-587000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":1352000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":382644000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":835000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.082,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":64446000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":77272000.0,"LeaseCost_1_Q2_USD":4183000.0,"LeaseCost_2_Q2_USD":8582000.0,"Liabilities_0_Q2_USD":239991000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1568795000.0,"LiabilitiesCurrent_0_Q2_USD":125397000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":21865000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":17021000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-188943000.0,"NetIncomeLoss_1_Q2_USD":-108444000.0,"NetIncomeLoss_2_Q2_USD":-208159000.0,"NonoperatingIncomeExpense_1_Q2_USD":260000.0,"NonoperatingIncomeExpense_2_Q2_USD":784000.0,"OperatingLeaseCost_1_Q2_USD":4451000.0,"OperatingLeaseCost_2_Q2_USD":9177000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":8465000.0,"OperatingLeasePayments_2_Q2_USD":7394000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValueOutstanding_0_Q2_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6198786.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":67.49,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":3428017.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":57.2,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":42.73,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":98.95,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice_2_Q2_USD":77.49,"StockholdersEquity_0_Q2_USD":1328804000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":468534.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1733000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":11710000.0,"SubleaseIncome_1_Q2_USD":268000.0,"SubleaseIncome_2_Q2_USD":595000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":58406000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":58216000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_2_Q2_shares":271982.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":908661.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":45734000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":24522000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":21270000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":400500000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q2_USD":185100000.0,"ProfitLoss_2_Q2_USD":-208159000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":54737000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":31848000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":80027000.0,"InventoryWriteDown_2_Q2_USD":400000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":159738000.0,"RestrictedCashNoncurrent_0_Q2_USD":5171000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-839514000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":27295000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":48871000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":49286000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":91288000.0,"ShareBasedCompensation_2_Q2_USD":44991000.0,"RestrictedCash_0_Q2_USD":5200000.0,"InventoryWriteDown_1_Q2_USD":400000.0,"InventoryNoncurrent_0_Q2_USD":3639000.0,"InventoryNet_0_Q2_USD":15211000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":1380100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":539488000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-150057000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"CommonStockSharesIssued_0_Q2_shares":58554559.0,"CommonStockSharesOutstanding_0_Q2_shares":58554559.0,"CommonStockValue_0_Q2_USD":59000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-109182000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-208779000.0,"ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_0_Q2_USD":2554000.0,"ContractWithCustomerAssetAllowanceForCreditLossRecovery_2_Q2_USD":1837000.0,"ContractWithCustomerAssetCreditLossExpense_2_Q2_USD":3199000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":7912000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":534317000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":230000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":751702000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":94032000.0,"AccountsReceivableNetCurrent_0_Q2_USD":25473000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":107173000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":14064000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":22889000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-5835000.0,"AdditionalPaidInCapital_0_Q2_USD":2174094000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":24522000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":30365000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":24307000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7780000.0,"Assets_0_Q2_USD":1568795000.0,"AssetsCurrent_0_Q2_USD":704070000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":316000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":380000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q2_USD":751700000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":845734000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":44991000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":58406000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":6493000.0,"CostsAndExpenses_1_Q2_USD":135806000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-108251000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-207966000.0,"IncomeTaxesPaidNet_2_Q2_USD":598000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":193000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":193000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2544000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":18407000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-1044000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2880000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4542000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-3845000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":3829000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":755000.0,"InterestIncomeExpenseNet_1_Q2_USD":633000.0,"InterestIncomeExpenseNet_2_Q2_USD":1371000.0,"EntityListingParValuePerShare_2_Q2_USD":0.001,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":120200000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":743000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":215000.0,"CostsAndExpenses_2_Q2_USD":257621000.0,"DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_0_Q2_USD":845798000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_security":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":422800000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":35.0,"CostOfGoodsAndServicesSold_2_Q2_USD":6595000.0,"Depreciation_1_Q2_USD":1600000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3200000.0,"EarningsPerShareBasic_1_Q2_USD":-1.86,"EarningsPerShareBasic_2_Q2_USD":-3.58,"EarningsPerShareDiluted_1_Q2_USD":-1.86,"EarningsPerShareDiluted_2_Q2_USD":-3.58,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-259000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":16667000.0,"Depreciation_2_Q2_USD":3200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":58216000.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]